Following my post last we
Mentioned already in some places on-line (including my twitter feed) but here's the details:
As two months have passed since my article USD IRSwap Client Clearing, CME or LCH?,
WE'RE NEARLY THERE
As hinted at yesterday, it appears that the only option available to delay ETD reporting is for ESMA not to approve any TR until the many data format and structural issues are resolved.
Overheard at a conference, a comment by Patrick Pearson: "there will be no delay to ETD reporting". Can anyone else confirm this? Bill
The apparently fast start (Monday) of the Fed's FARP - coming just after the unexpected announcement not to taper - has caused some to speculate this is an alternative to the taper. But is it?
On Sep 11, we went public with SDRFix and s
Customers of Abide and REGIS can now achieve compliance with both EMIR and MiFID as the two firms have announced a link-up.
In this issue, industry experts opinions are expressed in many of the most important issues that face global Financial Services Firms today. Topics covered include:
As EMIR moves forward to its next milestones, central clearing, one of its major pillars (if not the core of EMIR) , is the next big challenge for all of us, assuming that trade reporting is already analysed and now in a testing phase.
With the departure of Ian Axe, Michael Davie has become CEO of LCH Ltd, with Jacques Again, Chairman of LCH Group, becoming Interim Executive Chairman of LCH Group, bridging Ltd and SA in Paris.
One of the major differences between EMIR and DFA is that under EMIR, both counterparties have the responsiblity to report using a single UTI.
Previously SEFs and market participants assumed the SEF mandate would come in in a somewhat manageable fashion for a subset of clearing mandated products ("required transactions") with obligations only really biting for C2D trading late Q4 / early
A commercial law firm Nabarro LLP has put together a short Q&A on EMIR, answering the following questions:
CME saw a 62% increase in trade volumes in September, nice for them.
Eurex are steadily signing up members for their OTC clearing services, the current list looks like this:
I have an iPad 3, and the new iOS 7 is pants. There's a keyboard delay / lag bug, and the general response to swipes is unreliable. There's plenty of discussion on-line about the issues, it's an iDisappointment that doesn't "just work".